Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating uremia and urine protein

A proteinuria and uremia technology, applied in the field of medicine, can solve problems such as the inability to effectively control the development of CRF, and achieve the effect of improving the nutritional status of the body and improving the therapeutic effect

Pending Publication Date: 2016-05-25
程潜
View PDF5 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, Western medicine mainly treats CRF patients in the uremia stage with dialysis and kidney transplantation, but there is no specific drug for early and mid-stage CRF, and most of them rely on passive symptomatic treatment, which cannot effectively control the development of CRF

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating uremia and urine protein
  • Medicine for treating uremia and urine protein
  • Medicine for treating uremia and urine protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Embodiment 1 A kind of medicine for treating uremia and urinary protein

[0031] The drug is marine algae glycoprotein;

[0032] The marine algae glycoprotein, by weight content, includes 1% sugar and 99% protein;

[0033] The molecular weight is 0.2kDa;

[0034] The sugar is a polysaccharide;

[0035] The marine algae are cyanobacteria;

[0036] The polysaccharides include: glucose, galactose, mannose, rhamnose;

[0037] The protein includes: arginine, lysine, serine, threonine;

Embodiment 2

[0038] Embodiment 2 A kind of medicine for treating uremia and urinary protein

[0039] The drug is marine algae glycoprotein;

[0040] Said marine algae glycoprotein, by weight content, comprises sugar 7%, protein 88%,

[0041] The molecular weight is 19kDa;

[0042] The sugar is a polysaccharide;

[0043] The marine algae is: green algae;

[0044] The polysaccharides include: glucose, galactose, mannose, rhamnose;

[0045] The protein includes: arginine, lysine, serine, threonine;

Embodiment 3

[0046] Embodiment 3 A kind of medicine for treating uremia and urinary protein

[0047] The drug is marine algae glycoprotein;

[0048] Said marine algae glycoprotein, by weight content, comprises sugar 22%, protein 72%,

[0049] The molecular weight is 5kDa;

[0050] The sugar is a polysaccharide;

[0051] The marine algae are: cyanobacteria;

[0052] The polysaccharides include: glucose, galactose, mannose, rhamnose;

[0053] The protein includes: arginine, lysine, serine, threonine;

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention provides medicine for treating uremia and urine protein. The medicine is a mixture of glycoprotein or polysaccharide and protein or polypeptide or protein. The medicine achieves a good treatment effect for uremia and urine protein, and after three treatment courses are completed, the total effective rate is 84-94%; the medicine lowers toxin of uremia and urine protein and remarkably lowers the content of SCr, the content of urine protein and the content of blood urea nitrogen, after three treatment courses are completed, the SCr content of a patient is 282.4-290. micromole / L, the urine protein content is 2.42-2.54 g / 24h, and the blood urea nitrogen content is 14.2-15.0 mmol / L. The medicine improves the nutrition condition of the organism, raises the content of plasma albumin (Alb) and the content of hemoglobin (Hb), improves the immunity, has the advantages of being safe, high in efficiency and free of side effect and has an obvious treatment effect for uremia and urine protein.

Description

technical field [0001] The invention relates to a medicine for treating uremia and urinary protein, belonging to the technical field of medicine. Background technique [0002] Chronic renal failure refers to a clinical syndrome composed of a series of symptoms and metabolic disorders caused by various kidney diseases leading to progressive and irreversible decline in renal function until the loss of function, referred to as chronic renal failure. The end stage of chronic renal failure is what is often called uremia. Uremia is not an independent disease, but a clinical syndrome shared by various advanced kidney diseases, which is a syndrome composed of a series of clinical manifestations when chronic renal failure enters the terminal stage. [0003] Kidney disease is a clinical common disease, frequently-occurring disease. In recent years, the incidence rate has gradually increased, which is extremely harmful to people's health. Various kidney diseases develop to eventuall...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/14A61P13/12A61K31/7012A61K36/704
CPCA61K31/7012A61K36/11A61K36/195A61K36/315A61K36/66A61K36/704A61K38/14A61K2300/00A61K38/00A61K36/05A61K36/505A61K31/7016A61K31/715A61P13/02A61K31/404A61K36/03A61K36/04A61K36/02
Inventor 程潜徐宝贞程龙
Owner 程潜
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com